Early Access & Testing

CURRENT INFORMATION

Early access programme

Axonevo is developing a digital learning and simulation platform for medical education. As part of an early access programme, selected users are given the opportunity to gain early access to initial features and to help shape their further development.

TARGET GROUP

Who can take part?

The early access programme is aimed at:

• Medical students in clinical training years in Switzerland

• Junior doctors in clinical training in Switzerland

• Resident doctors in Switzerland

Prior knowledge in specific specialties is not required. What matters is the willingness to actively test the platform and provide constructive feedback.

WHAT IS IT ABOUT

What does the early access offer?

Participants receive access to a learning and simulation environment that is currently under development. Possible content may include, for example:

• Structured case examples with clear questions

• Step-by-step decision pathways in clinically oriented situations (without real patient data)

• Immediate feedback on selected options

• Insights into new features before they become generally available

Important: The platform is in the development phase. No clinical application takes place.

As an early access participant, you actively help shape the further development of Axonevo. Your feedback feeds directly into the creation of a digital simulation platform intended to make clinical learning better, more practice-oriented and more understandable in the future, for you and for future generations of students.

• Specifically, this means:

• You test new features at your own learning pace

• You provide feedback on clarity, user guidance and content relevance

• You help identify improvements and missing content at an early stage

The programme is voluntary and exclusively focused on individual learning and practice.

WARUM DAS WICHTIG IST

Rolle der Teilnehmenden

Interested in early access to Axonevo?

Leave your contact details and a few brief details about your stage of training.

We will get in touch with you as soon as early access becomes available.

Participation is voluntary and intended exclusively for learning and practice purposes.